Newswise reports that Penn Medicine has secured a $12 million grant that will help researchers at the Abramson Cancer Center at the University of Pennsylvania to pursue next generation cancer treatments. This money will support the quest to understand the genetics of cancer cells to improving cellular therapies and incorporating new methods of radiation therapy.
The grant was awarded by the Mark Foundation for Cancer Research. The gift will create the Mark Foundation Center for Immunotherapy, Immune Signaling and Radiation at the University of Pennsylvania. The university will seek to better understand the interconnected relationship between novel forms of radiation therapy, important signaling pathways between cancer and immune cells, and the immune system’s ability to kill cancer. The funding will help support five specific projects that bring together these multidisciplinary teams of basic science and clinical researchers to address these key questions.
Andy J. Minn, MD, PHD